Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C068073 |
Am 580 |
Am 580 results in decreased expression of METRN mRNA | decreases expression | 16982809
|
D003520 |
Cyclophosphamide |
METRN mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of METRN mRNA | decreases expression | 20106945
|
D004317 |
Doxorubicin |
METRN mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
C056516 |
exemestane |
exemestane results in increased expression of METRN mRNA | increases expression | 17254854
|
D005472 |
Fluorouracil |
METRN mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D017239 |
Paclitaxel |
METRN mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
C089730 |
rosiglitazone |
rosiglitazone results in decreased expression of METRN mRNA | decreases expression | 16982809
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of METRN mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.77 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.13 | 19490988 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.76 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.76 | 17638652 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.78 | 21441931 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
2.89 | 19621015 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.55 | 17688650 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
3.90 | 17963324 15504547 16511603 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.74 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
4.86 | 15014928 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 18985861 17507914 17157402 18316065 19460635 20603192 18396377 15238991 18558336 17688650 18940202 16609825 19232924 18775368 18177632 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.17 | 17594078 20046352 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.52 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.02 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.79 | 15867366 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.00 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
2.46 | 17020986 17388661 15136595 18234424 15093573 11325840 18323546 12006526 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.46 | 17426702 19526202 17369602 18695136 15136595 16264153 15994142 18628466 16595493 15939500 15634643 16096432 16935488 11325840 16826403 16115903 18234424 15692762 17983394 15668708 15567936 15993339 18382427 16322301 |
MESH:D001943 |
Breast Neoplasms |
|
exemestane |
2.46 | 17892469 16002280 17952589 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.46 | 16595493 19217205 16557594 16110121 18608205 15136595 18357371 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
2.46 | 16244791 18223236 16273361 18234424 15136595 16115903 18323546 11325840 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
13.44 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
13.44 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
3.73 | 17121937 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
6.91 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
6.91 | 18059187 16023760 17876044 16234567 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
6.91 | 16799960 17045692 16332177 17971768 17088986 18930000 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
6.91 | 16313753 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
5.17 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
11.40 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
11.40 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
11.40 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
5.03 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
5.03 | 16280240 16757204 18986760 17066447 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.66 | 17007740 17329180 17924179 16364871 15792986 16612575 16242529 17519947 17928571 15476868 15505089 18627295 16269455 17131338 16455267 17308081 16952015 17351982 16109756 16651473 16278810 16731534 15811867 17974986 17382496 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.00 | 16243910 17334414 |
MESH:D002386 |
Cataract |
|
Am 580 |
4.46 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.66 | 12371664 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.77 | 20734317 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.06 | 19486331 |
MESH:D003092 |
Colitis |
|
Am 580 |
5.22 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.26 | 15001691 17172411 17725105 18772588 16510598 17287894 17016597 17018589 16340194 17169374 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.64 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
3.64 | 18448328 20501625 18288408 16524972 18949393 17454858 14970324 16303861 17594712 18509181 15289873 18383874 16391804 17401013 17094418 16331619 15148649 17695437 17255274 16282729 17016601 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
3.64 | 18802399 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 17688650 16575769 8888407 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
5.30 | 15276878 17010015 12161096 12388444 18093676 18483878 15643279 11948286 12913760 16651033 18433785 17979934 16413132 10700343 16614059 18710439 10498854 18372110 16989017 18295254 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
5.08 | 16733453 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
4.48 | 17446233 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.24 | 10990075 15331540 11751995 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.27 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
2.98 | 12642470 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
4.28 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
4.28 | 19641884 1733752 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.82 | 18602426 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.27 | 1851702 |
MESH:D004487 |
Edema |
|
rosiglitazone |
3.85 | 12083418 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.58 | 17359293 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.47 | 18037988 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.47 | 11006010 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.41 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.23 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.03 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.77 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.56 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.35 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.96 | 16785472 16337965 16481741 15173087 17638652 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
4.96 | 16481741 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
14.46 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
14.46 | 19196556 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
14.46 | 14986274 19224547 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.20 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.37 | 8888407 18558336 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.87 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.40 | 12168785 12639820 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.50 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.47 | 17150277 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.94 | 16145905 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.80 | 11389073 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.29 | 16376943 15172196 11014644 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
8.36 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
8.36 | 15162350 18337622 15102660 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.62 | 16879835 16330681 17875725 16244371 16244372 16144979 14766674 17888722 16495754 12587719 18006777 18674790 16707910 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.46 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.11 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.71 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.55 | 11918545 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.85 | 14986274 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
8.32 | 16135485 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
8.32 | 17606976 18501091 15147373 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.15 | 17688650 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
4.08 | 12083418 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.16 | 10903974 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.65 | 16076520 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
3.75 | 16517039 7193160 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
3.22 | 12083418 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
3.93 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.76 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.47 | 8314463 18776723 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.47 | 15369732 15699352 16775033 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.36 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.97 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
7.97 | 16985049 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
3.58 | 10602166 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.47 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.57 | 18587576 18172266 17008537 17802794 17296974 17658394 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.24 | 10373061 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.18 | 16294345 17596541 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
5.25 | 11830472 10052129 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
5.04 | 17353645 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.95 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
2.95 | 15980055 17347453 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
2.54 | 16603448 18383874 15113037 17045692 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
3.13 | 17085340 16842330 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.58 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.73 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
2.73 | 15246190 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
5.08 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
8.36 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
8.36 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.82 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
15.71 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
15.71 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
15.71 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.83 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
6.84 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
6.84 | 16827153 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.77 | 16827129 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
3.77 | 16342250 12025231 12040289 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
5.06 | 16388313 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.13 | 17638057 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
4.55 | 17261469 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.11 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.33 | 18765137 18803445 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.70 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.79 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.08 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
3.83 | 14749477 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.23 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.26 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.02 | 19429709 15857846 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
6.37 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
6.37 | 15867366 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
5.72 | 18854779 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
5.72 | 18239605 18600527 16928823 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.03 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.76 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.91 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.91 | 16889571 15640375 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.25 | 16359493 8888407 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
7.53 | 8761367 15176712 16115947 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
7.53 | 15555623 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
5.17 | 12837982 8761367 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.57 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.54 | 8291058 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
5.00 | 16517039 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
5.26 | 15867366 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.28 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
3.04 | 11161223 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.79 | 12161096 18093676 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
5.82 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.82 | 15113037 16929163 19003803 16500647 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.47 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.47 | 17638057 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.40 | 12371664 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.91 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.11 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.14 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.14 | 15897917 16729912 18437689 16888761 16868541 15749863 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.14 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
2.14 | 17172428 17136230 16356831 16729912 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.86 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.29 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.35 | 16636934 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.19 | 16160472 15538739 18286688 18722050 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.48 | 17922066 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.40 | 19155313 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.18 | 18313854 16767912 15675481 15625365 17203757 17710206 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.48 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.08 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 15737665 19110320 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
5.04 | 16636934 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.87 | 3137016 11738929 15475178 16876388 1511512 17978042 14763951 11044598 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
3.03 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.83 | 17203757 15625365 16767912 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.80 | 16517039 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.94 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.86 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.79 | 18567086 19084572 17522103 19015929 16424979 17498489 18396642 17172411 16951190 15786421 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
2.79 | 18396642 18506536 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.34 | 12837982 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
5.10 | 16930453 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.52 | 17909728 16010429 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
4.18 | 16280240 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.55 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.81 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
5.73 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.73 | 17653716 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.90 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
4.07 | 16803524 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.30 | 1336536 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.48 | 17638931 17678736 16364871 17334414 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.76 | 17120751 |